Catalyst Wire Dossier Catalyst Wire Dossier

Botulinum Neurotoxin Type A

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Botulinum Neurotoxin Type A, covering 2020-07-09 to 2020-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Comparative Study of Botulinum Neurotoxin Type A in Treatment of Moderate to Severe Glabellar Frown Lines [Phase 1, Phase 2]

See pricing